Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Meta‐analysis: vasoactive medications for the management of acute variceal bleeds
2012
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study
1999
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 Standout
Combination of direct and indirect evidence in mixed treatment comparisons
2004 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Maintenance treatment of Crohn's disease
2003
Cancer risk in patients with inflammatory bowel disease
2001 Standout
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
2000 StandoutNature
Classification and Grading of Gastritis
1996 Standout
Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease
2006
The multitude and diversity of environmental carcinogens
2007 StandoutNobel
9 Prognostic parameters of Crohn's disease recurrence
1998
Effects of Endoscopic Variceal Ligation on Portal Hypertensive Gastropathy and Gastric Mucosal Blood Flow
1998
Beta adrenergic blockade and decompensated cirrhosis
2016
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Ulcerative Colitis
2011 Standout
Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension
2007
Risk Factors Regarding the Need for a Second Operation in Patients with Crohn’s Disease
2005
Burden of liver diseases in the world
2018 Standout
Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis
2007 Nature
Risk Factors for Surgery and Postoperative Recurrence in Crohn’s Disease
2000
Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease
1999
Effects of light smoking consumption on the clinical course of Crohnʼs disease
2008
Portal hypertension and variceal bleeding: An AASLD single topic symposium†
1998
Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice
2004
Infections and IBD
2008
Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: A controlled study
2002
Guidelines for the management of inflammatory bowel disease in adults
2011
Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence
2004
Hepatitis C Infection
2017
Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93
1997
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension
1996
Hepatocellular carcinoma
2021 Standout
Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease
2003
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Operative Management of Small Bowel Crohn's Disease
2007
Perianal Crohn Disease
2005
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation
1998
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy1
2002
Risk Factors for Surgical Recurrence after Ileocolic Resection of Crohn's Disease
2008
Portal Hypertensive Gastropathy and Colopathy
2014
Expanding consensus in portal hypertension
2015 Standout
Has disease outcome in Crohn's disease changed during the last four decades?
2004
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study
2007
Smoking cessation and the course of Crohn's disease: An intervention study
2001
Acute Pancreatitis
2016 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
2017
The Natural History of Portal Hypertensive Gastropathy in Patients with Liver Cirrhosis and Mild Portal Hypertension
2004
Inflammatory Bowel Disease and Smoking
2004
The chances of hepatic resection curing hepatocellular carcinoma
2019
Portal hypertensive bleeding in cirrhosis
2016 Standout
Ulcerative colitis
2012 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-α via the PI 3-kinase-Akt signaling pathway
2002
Prevention of First Bleeding in Cirrhosis
1992
Pediatric Crohn's disease: risk factors for postoperative recurrence
2001
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis
2010
Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients
1995
Smoking and inflammatory bowel disease
2007
Global burden of liver disease: 2023 update
2023 Standout
Ulcerative colitis
2016 Standout
Cytomegalovirus and ulcerative colitis: Place of antiviral therapy
2016
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
2016
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients
2008
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE
1999
Periodontal diseases
2017 Standout
Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease
1998
Acute Cytomegalovirus Infection Is a Risk Factor in Refractory and Complicated Inflammatory Bowel Disease
2008
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Ulcerative colitis
2020 Standout
Practice Guidelines for Inflammatory Bowel Disease: An Instrument for Assessment
1999
Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy
2008
Inflammatory Bowel Disease and Smoking—A Review
1998
Endoscopic management of pancreatic pseudocysts and necrosis
2014
Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers
2010
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis
1995
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Effects of Current Cigarette Smoking on Clinical Course of Crohn's Disease and Ulcerative Colitis
2001
European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations
2006
Clinical states of cirrhosis and competing risks
2017
The global burden of IBD: from 2015 to 2025
2015 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Portal Hypertensive Gastropathy
2002
Impact of cessation of smoking on the course of ulcerative colitis
2001
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study
1998
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Guidelines for the management of inflammatory bowel disease in adults
2004
Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
2017
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis
2012
The treatment of portal hypertension: A meta-analytic review
1995
Meta‐analysis: isosorbide‐mononitrate alone or with either beta‐blockers or endoscopic therapy for the management of oesophageal varices
2010
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Review article: the natural history of postoperative C rohn's disease recurrence
2012
Hepatocellular Carcinoma
2019 Standout
A Case-Control Study to Examine the Influence of Maternal Perinatal Behaviors on the Incidence of Crohnʼs Disease
1996
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Nicotine treatment for ulcerative colitis
1999
Breast Cancer Risk and the Combined Effect of Environmental Estrogens
2004
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Exposure to PCB and p, p′-DDE in European and Inuit populations: impact on human sperm chromatin integrity
2005
Clinical Practice Guideline for the Surgical Management of Crohn’s Disease
2015
Inflammatory bowel disease: Is there any relation between smoking status and disease presentation?
2007
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Workshop Report: Prevention of Postoperative Recurrence in Crohn's Disease
2005
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Transdermal nicotine inhibits interleukin 2 synthesis by mononuclear cells derived from healthy volunteers
1998
Prevalence of portal hypertensive duodenopathy in cirrhosis: clinical and haemodynamic features
2006
Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study
2016
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
The association between smoking and inflammatory bowel disease among Israeli Jewish patients
1997
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α
2008 StandoutNobel
Pediatric Crohn's disease: risk factors for postoperative recurrence
2001
Effects of current and former cigarette smoking on the clinical course of Crohn’s disease
1999
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
Selective cyclooxygenase (COX) inhibition causes damage to portal hypertensive gastric mucosa: roles of nitric oxide and NF‐κB
2005
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
1996
Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy.
1995
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Preventing postoperative recurrence of Crohn's disease.
1997
Risk factors for early postoperative recurrence of Crohn's disease
1998
Works of Mario Traina being referenced
Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis
1994
Natural history of congestive gastropathy in cirrhosis
1990
Long-lasting effects of lindane on mouse spermatogenesis induced by in utero exposure
2002
Severe acute colitis associated with CMV: a prevalence study
2004
Octreotide Compared With Placebo in A Treatment Strategy for Early Rebleeding in Cirrhosis. A Double Blind, Randomized Pragmatic Trial
1998
Smoking habits and recurrence in Crohn's disease
1994
Endoscopic ultrasound-guided transmural drainage of infected pancreatic fluid collections with placement of covered self-expanding metal stents: a case series
2012
Isosorbide monitrate with nadolol campared to nadolol alone for prevention of recurrent bleeding in cirrhosis. A double blind placebo controlled randomized trial. Final report
2001
Natural history of cirrhosis
1991
Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of recurrent bleeding in cirrhosis. A double-blind placeho-controlled randomised
2001
Hemospray for arterial hemorrhage following endoscopic ultrasound -guided pseudocyst drainage
2014
Predictive value of ultrasonography in the screening of non-ascitic cirrhotic patients with large varices.
1986
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
2014